Genetics of multiple sclerosis
- PMID: 14747002
- DOI: 10.1016/s1474-4422(03)00663-x
Genetics of multiple sclerosis
Abstract
Multiple sclerosis (MS) is probably aetiologically heterogeneous. Systematic genetic epidemiological and molecular genetic studies have provided important insights. Both genetic and non-genetic (environment, stochastic) factors may be involved in susceptibility as well as outcome, but we have yet to understand their relative roles. Any environmental factor is likely to be ubiquitous and act on a population-basis rather than within the family microenvironment. Taken together, the results of genome screening studies provide strong evidence for exclusion of a major locus in MS. There are, however, many genes that seem to be associated with MS. These include, but are in no way limited to, HLA classes I and II, T-cell receptor beta, CTLA4, ICAM1, and SH2D2A. The future of MS genetics, as for most common complex disorders, will be dependent on the resources available, ranging from biological samples and comprehensive databases of clinical and epidemiological information to the development of new technologies and statistical methods.
Similar articles
-
No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study.J Neuroimmunol. 2002 Feb;123(1-2):193-8. doi: 10.1016/s0165-5728(01)00493-3. J Neuroimmunol. 2002. PMID: 11880164
-
Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.Ann Neurol. 2003 Jul;54(1):119-22. doi: 10.1002/ana.10617. Ann Neurol. 2003. PMID: 12838528 Review.
-
CTLA4 is associated with susceptibility to multiple sclerosis.J Neuroimmunol. 2003 Jan;134(1-2):133-41. doi: 10.1016/s0165-5728(02)00395-8. J Neuroimmunol. 2003. PMID: 12507781
-
The genetics of clinical outcome in multiple sclerosis.J Neuroimmunol. 2008 Sep 15;201-202:183-99. doi: 10.1016/j.jneuroim.2008.02.016. Epub 2008 Jul 15. J Neuroimmunol. 2008. PMID: 18632165 Review.
-
[Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians].Mol Biol (Mosk). 2002 Jul-Aug;36(4):643-8. Mol Biol (Mosk). 2002. PMID: 12173468 Russian.
Cited by
-
Age-standardized incidence, prevalence, and mortality rates of autoimmune diseases in adolescents and young adults (15-39 years): an analysis based on the global burden of disease study 2021.BMC Public Health. 2024 Jul 5;24(1):1800. doi: 10.1186/s12889-024-19290-3. BMC Public Health. 2024. PMID: 38970015 Free PMC article.
-
Medicinal herbal remedies in neurodegenerative diseases: an update on antioxidant potential.Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5483-5511. doi: 10.1007/s00210-024-03027-5. Epub 2024 Mar 13. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38472370 Review.
-
Role of fenofibrate in multiple sclerosis.Eur J Med Res. 2024 Feb 9;29(1):113. doi: 10.1186/s40001-024-01700-2. Eur J Med Res. 2024. PMID: 38336772 Free PMC article. Review.
-
IgA nephropathy.Nat Rev Dis Primers. 2023 Nov 30;9(1):67. doi: 10.1038/s41572-023-00476-9. Nat Rev Dis Primers. 2023. PMID: 38036542 Review.
-
Genetic Basis of Inflammatory Demyelinating Diseases of the Central Nervous System: Multiple Sclerosis and Neuromyelitis Optica Spectrum.Genes (Basel). 2023 Jun 23;14(7):1319. doi: 10.3390/genes14071319. Genes (Basel). 2023. PMID: 37510224 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
